{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:39:23Z","timestamp":1789396763282,"version":"build-2803163510"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","medical-hypotheses.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.mehy.2016.04.039","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T16:16:49Z","timestamp":1461946609000},"page":"67-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Colchicine to decrease NLRP3-activated inflammation and improve obesity-related metabolic dysregulation"],"prefix":"10.1016","volume":"92","author":[{"given":"Andrew P.","family":"Demidowich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela I.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicket","family":"Dedhia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack A.","family":"Yanovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2016.04.039_b0005","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/eurheartj\/ehi506","article-title":"Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew\u2013Paisley study)","volume":"27","author":"Murphy","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mehy.2016.04.039_b0010","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.295.13.1549","article-title":"Prevalence of overweight and obesity in the United States, 1999\u20132004","volume":"295","author":"Ogden","year":"2006","journal-title":"Jama-J Am Med Assoc"},{"key":"10.1016\/j.mehy.2016.04.039_b0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/jama.1994.03520030047027","article-title":"Increasing prevalence of overweight among US adults. The national health and nutrition examination surveys, 1960\u20131991","volume":"272","author":"Kuczmarski","year":"1994","journal-title":"JAMA J Am Med Assoc"},{"key":"10.1016\/j.mehy.2016.04.039_b0020","doi-asserted-by":"crossref","first-page":"E166","DOI":"10.1152\/ajpendo.00284.2006","article-title":"Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins","volume":"292","author":"Lumeng","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.mehy.2016.04.039_b0025","doi-asserted-by":"crossref","first-page":"48115","DOI":"10.1074\/jbc.M209459200","article-title":"Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex","volume":"277","author":"Gao","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2016.04.039_b0030","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ceca.2011.08.005","article-title":"The central role of calcium in the effects of cytokines on beta-cell function: implications for type 1 and type 2 diabetes","volume":"50","author":"Ramadan","year":"2011","journal-title":"Cell Calcium"},{"key":"10.1016\/j.mehy.2016.04.039_b0035","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ceca.2010.07.007","article-title":"Evidence that low-grade systemic inflammation can induce islet dysfunction as measured by impaired calcium handling","volume":"48","author":"Dula","year":"2010","journal-title":"Cell Calcium"},{"key":"10.1016\/j.mehy.2016.04.039_b0040","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","article-title":"Inflammation in atherosclerosis: from pathophysiology to practice","volume":"54","author":"Libby","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mehy.2016.04.039_b0045","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1096\/fj.04-2204com","article-title":"Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects","volume":"18","author":"Clement","year":"2004","journal-title":"Faseb J"},{"key":"10.1016\/j.mehy.2016.04.039_b0050","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1212914","article-title":"Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes","volume":"369","author":"Wing","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2016.04.039_b0055","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","article-title":"10-year follow-up of diabetes incidence and weight loss in the diabetes prevention program outcomes study","volume":"374","author":"Knowler","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2016.04.039_b0060","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s11695-007-9265-1","article-title":"Long-term weight regain after gastric bypass: a 5-year prospective study","volume":"18","author":"Magro","year":"2008","journal-title":"Obes Surg"},{"key":"10.1016\/j.mehy.2016.04.039_b0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11695-008-9675-8","article-title":"Successful multi-intervention treatment of severe obesity: a 7-year prospective study with 96% follow-up","volume":"19","author":"Steffen","year":"2009","journal-title":"Obes Surg"},{"key":"10.1016\/j.mehy.2016.04.039_b0070","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.2013.281361","article-title":"Long-term drug treatment for obesity: a systematic and clinical review","volume":"311","author":"Yanovski","year":"2014","journal-title":"JAMA J Am Med Assoc"},{"key":"10.1016\/j.mehy.2016.04.039_b0075","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrd1279","article-title":"The IKK NF-kappa B system: a treasure trove for drug development","volume":"3","author":"Karin","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.mehy.2016.04.039_b0080","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2016.04.039_b0085","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0092-8674(00)81375-6","article-title":"Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death","volume":"87","author":"Liu","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.mehy.2016.04.039_b0090","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature01137","article-title":"A central role for JNK in obesity and insulin resistance","volume":"420","author":"Hirosumi","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2016.04.039_b0095","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nm1185","article-title":"IKK-beta links inflammation to obesity-induced insulin resistance","volume":"11","author":"Arkan","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.mehy.2016.04.039_b0100","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm1166","article-title":"Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB","volume":"11","author":"Cai","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.mehy.2016.04.039_b0105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.2279","article-title":"The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance","volume":"17","author":"Vandanmagsar","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.mehy.2016.04.039_b0110","doi-asserted-by":"crossref","first-page":"42394","DOI":"10.1074\/jbc.C200444200","article-title":"SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2","volume":"277","author":"Rui","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2016.04.039_b0115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cyto.2008.07.004","article-title":"Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity","volume":"44","author":"Osborn","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.mehy.2016.04.039_b0120","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1152\/physrev.00042.2009","article-title":"Islet amyloid polypeptide, islet amyloid, and diabetes mellitus","volume":"91","author":"Westermark","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1016\/j.mehy.2016.04.039_b0125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","article-title":"Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"issue":"Suppl 2","key":"10.1016\/j.mehy.2016.04.039_b0130","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.2337\/diabetes.54.suppl_2.S108","article-title":"Mechanisms of beta-cell death in type 2 diabetes","volume":"54","author":"Donath","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2016.04.039_b0135","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.cmet.2010.11.011","article-title":"The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity","volume":"12","author":"Stienstra","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/j.mehy.2016.04.039_b0140","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.2337\/db10-1278","article-title":"Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis","volume":"60","author":"McGillicuddy","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2016.04.039_b0145","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.mehy.2016.04.039_b0150","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1172\/JCI26498","article-title":"MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity","volume":"116","author":"Kanda","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2016.04.039_b0155","doi-asserted-by":"crossref","first-page":"e113369","DOI":"10.1371\/journal.pone.0113369","article-title":"Macrophage migration inhibitory factor deficiency ameliorates high-fat diet induced insulin resistance in mice with reduced adipose inflammation and hepatic steatosis","volume":"9","author":"Finucane","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mehy.2016.04.039_b0160","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1172\/JCI118404","article-title":"Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide","volume":"97","author":"Samad","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2016.04.039_b0165","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/sj.ijo.0801792","article-title":"The relation of body fat mass and distribution to markers of chronic inflammation","volume":"25","author":"Festa","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.mehy.2016.04.039_b0170","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/sj.ijo.0801719","article-title":"C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women","volume":"25","author":"Pannacciulli","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.mehy.2016.04.039_b0175","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.diabres.2004.11.007","article-title":"Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6","volume":"69","author":"Park","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.mehy.2016.04.039_b0180","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1001\/jama.282.22.2131","article-title":"Elevated C-reactive protein levels in overweight and obese adults","volume":"282","author":"Visser","year":"1999","journal-title":"JAMA: J Am Med Assoc"},{"key":"10.1016\/j.mehy.2016.04.039_b0185","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/BF03347427","article-title":"The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults?","volume":"30","author":"Bahceci","year":"2007","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.mehy.2016.04.039_b0190","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.metabol.2005.03.022","article-title":"High-sensitive C-reactive protein, tumor necrosis factor alpha, and cardiovascular risk factors before and after weight loss in obese children","volume":"54","author":"Reinehr","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.mehy.2016.04.039_b0195","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.metabol.2010.03.023","article-title":"Changes in adipose-derived inflammatory cytokines and chemokines after successful lifestyle intervention in obese children","volume":"60","author":"Roth","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.mehy.2016.04.039_b0200","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00431-010-1356-7","article-title":"Metabolic, inflammatory, endothelial and haemostatic markers in a group of Italian obese children and adolescents","volume":"170","author":"Giordano","year":"2011","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.mehy.2016.04.039_b0205","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/oby.2011.85","article-title":"Markers of inflammation and fat distribution following weight loss in African-American and white women","volume":"20","author":"Fisher","year":"2012","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.mehy.2016.04.039_b0210","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1007\/s11695-012-0643-y","article-title":"Obesity and inflammation: change in adiponectin, C-reactive protein, tumour necrosis factor-alpha and interleukin-6 after bariatric surgery","volume":"22","author":"Illan-Gomez","year":"2012","journal-title":"Obes Surg"},{"key":"10.1016\/j.mehy.2016.04.039_b0215","doi-asserted-by":"crossref","first-page":"E53","DOI":"10.1210\/jc.2013-2673","article-title":"Adipose inflammation in obesity: relationship with circulating levels of inflammatory markers and association with surgery-induced weight loss","volume":"99","author":"Lasselin","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2016.04.039_b0220","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"Weisberg","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2016.04.039_b0225","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-065X.2012.01151.x","article-title":"The inflammation highway: metabolism accelerates inflammatory traffic in obesity","volume":"249","author":"Johnson","year":"2012","journal-title":"Immunol Rev"},{"key":"10.1016\/j.mehy.2016.04.039_b0230","doi-asserted-by":"crossref","first-page":"7833","DOI":"10.1073\/pnas.0802063105","article-title":"Cidea is associated with lipid droplets and insulin sensitivity in humans","volume":"105","author":"Puri","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2016.04.039_b0235","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1172\/JCI29881","article-title":"Obesity induces a phenotypic switch in adipose tissue macrophage polarization","volume":"117","author":"Lumeng","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2016.04.039_b0240","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1096\/fj.04-2204com","article-title":"Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects","volume":"18","author":"Clement","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.mehy.2016.04.039_b0245","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2337\/db06-1076","article-title":"Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity","volume":"56","author":"Lumeng","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2016.04.039_b0250","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1210\/en.2009-1124","article-title":"XOMA 052, an anti-IL-1\u03b2 monoclonal antibody, improves glucose control and \u03b2-cell function in the diet-induced obesity mouse model","volume":"151","author":"Owyang","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.mehy.2016.04.039_b0255","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1210\/en.2007-1059","article-title":"The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia","volume":"149","author":"Sauter","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.mehy.2016.04.039_b0260","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2337\/diab.45.7.881","article-title":"Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM","volume":"45","author":"Ofei","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2016.04.039_b0265","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1210\/en.2004-1468","article-title":"Interleukin-6 depletion selectively improves hepatic insulin action in obesity","volume":"146","author":"Klover","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.mehy.2016.04.039_b0270","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1172\/JCI24335","article-title":"CCR2 modulates inflammatory and metabolic effects of high-fat feeding","volume":"116","author":"Weisberg","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2016.04.039_b0275","doi-asserted-by":"crossref","first-page":"e62068","DOI":"10.1371\/journal.pone.0062068","article-title":"Celastrol, an NF-kappaB inhibitor, improves insulin resistance and attenuates renal injury in db\/db mice","volume":"8","author":"Kim","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mehy.2016.04.039_b0280","doi-asserted-by":"crossref","first-page":"E146","DOI":"10.1210\/jc.2010-1170","article-title":"TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome","volume":"96","author":"Stanley","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2016.04.039_b0285","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/dc08-1206","article-title":"A randomized trial of low-dose aspirin in the prevention of clinical type 2 diabetes in women","volume":"32","author":"Pradhan","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mehy.2016.04.039_b0290","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1161\/CIRCULATIONAHA.112.122556","article-title":"Effects of interleukin-1beta inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial","volume":"126","author":"Ridker","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2016.04.039_b0295","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/j.1463-1326.2012.01637.x","article-title":"Effect of anti-IL-1beta antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial","volume":"14","author":"Rissanen","year":"2012","journal-title":"Diab Obes Metab"},{"key":"10.1016\/j.mehy.2016.04.039_b0300","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.2337\/dc11-2219","article-title":"Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes","volume":"35","author":"Cavelti-Weder","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mehy.2016.04.039_b0305","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa065213","article-title":"Interleukin-1-receptor antagonist in type 2 diabetes mellitus","volume":"356","author":"Larsen","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2016.04.039_b0310","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1210\/jc.2010-2992","article-title":"Treatment with Anakinra improves disposition index but not insulin sensitivity in nondiabetic subjects with the metabolic syndrome: a randomized, double-blind, placebo-controlled study","volume":"96","author":"van Asseldonk","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2016.04.039_b0315","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1073\/pnas.82.21.7227","article-title":"Modes of action of aspirin-like drugs","volume":"82","author":"Abramson","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2016.04.039_b0320","doi-asserted-by":"crossref","first-page":"14540","DOI":"10.1073\/pnas.95.24.14540","article-title":"Modes of action of aspirin-like drugs: salicylates inhibit erk activation and integrin-dependent neutrophil adhesion","volume":"95","author":"Pillinger","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2016.04.039_b0325","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.8052854","article-title":"Inhibition of NF-kappa B by sodium salicylate and aspirin","volume":"265","author":"Kopp","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.mehy.2016.04.039_b0330","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-152-6-201003160-00004","article-title":"The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial","volume":"152","author":"Goldfine","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mehy.2016.04.039_b0335","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.4049\/jimmunol.1002720","article-title":"Differential expression of NLRP3 among hematopoietic cells","volume":"186","author":"Guarda","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2016.04.039_b0340","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2016.04.039_b0345","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2016.04.039_b0350","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ni.1935","article-title":"Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes","volume":"11","author":"Masters","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.mehy.2016.04.039_b0355","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbrc.2012.07.011","article-title":"Oxidized low-density lipoprotein induces secretion of interleukin-1beta by macrophages via reactive oxygen species-dependent NLRP3 inflammasome activation","volume":"425","author":"Jiang","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.mehy.2016.04.039_b0360","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bcp.2014.08.013","article-title":"Free fatty acids as modulators of the NLRP3 inflammasome in obesity\/type 2 diabetes","volume":"92","author":"Legrand-Poels","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.mehy.2016.04.039_b0365","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.immuni.2013.05.016","article-title":"K(+) efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter","volume":"38","author":"Munoz-Planillo","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.mehy.2016.04.039_b0370","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2016.04.039_b0375","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.cell.2013.02.054","article-title":"The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation","volume":"153","author":"Subramanian","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.mehy.2016.04.039_b0380","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ni.2550","article-title":"Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome","volume":"14","author":"Misawa","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.mehy.2016.04.039_b0385","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.coi.2011.07.005","article-title":"Cross-regulation between the IL-1beta\/IL-18 processing inflammasome and other inflammatory cytokines","volume":"23","author":"Barker","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.mehy.2016.04.039_b0390","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/eji.201141550","article-title":"A clinical perspective of IL-1beta as the gatekeeper of inflammation","volume":"41","author":"Dinarello","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.mehy.2016.04.039_b0395","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3389\/fimmu.2013.00289","article-title":"Interleukin-18 and IL-18 binding protein","volume":"4","author":"Dinarello","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.mehy.2016.04.039_b0400","doi-asserted-by":"crossref","first-page":"236839","DOI":"10.1155\/2015\/236839","article-title":"Interleukin-18 increases TLR4 and mannose receptor expression and modulates cytokine production in human monocytes","volume":"2015","author":"Dias-Melicio","year":"2015","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.mehy.2016.04.039_b0405","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/ni.2022","article-title":"Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling","volume":"12","author":"Wen","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.mehy.2016.04.039_b0410","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1210\/en.2011-1326","article-title":"Elimination of the NLRP3-ASC inflammasome protects against chronic obesity-induced pancreatic damage","volume":"152","author":"Youm","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.mehy.2016.04.039_b0415","doi-asserted-by":"crossref","first-page":"15324","DOI":"10.1073\/pnas.1100255108","article-title":"Inflammasome is a central player in the induction of obesity and insulin resistance","volume":"108","author":"Stienstra","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2016.04.039_b0420","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1007\/s00125-013-3023-9","article-title":"Obesity phenotype is related to NLRP3 inflammasome activity and immunological profile of visceral adipose tissue","volume":"56","author":"Esser","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.mehy.2016.04.039_b0425","first-page":"721","article-title":"Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever","volume":"16","author":"Kiraz","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.mehy.2016.04.039_b0430","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2133.1981.tb01713.x","article-title":"Colchicine in the treatment of the cutaneous manifestations of Behcet\u2019s disease","volume":"104","author":"Miyachi","year":"1981","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.mehy.2016.04.039_b0435","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/0003-4819-155-7-201110040-00359","article-title":"Colchicine for recurrent pericarditis (CORP): a randomized trial","volume":"155","author":"Imazio","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mehy.2016.04.039_b0440","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.2165\/11205470-000000000-00000","article-title":"Oral colchicine (Colcrys): in the treatment and prophylaxis of gout","volume":"70","author":"Yang","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.mehy.2016.04.039_b0445","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/med.20097","article-title":"Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin","volume":"28","author":"Bhattacharyya","year":"2008","journal-title":"Med Res Rev"},{"key":"10.1016\/j.mehy.2016.04.039_b0450","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s11926-008-0036-3","article-title":"Colchicine: its mechanism of action and efficacy in crystal-induced inflammation","volume":"10","author":"Nuki","year":"2008","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.mehy.2016.04.039_b0455","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s10753-012-9428-7","article-title":"The effect of regular colchicine treatment on biomarkers related with vascular injury in newly diagnosed patients with familial Mediterranean fever","volume":"35","author":"Sari","year":"2012","journal-title":"Inflammation"},{"key":"10.1016\/j.mehy.2016.04.039_b0460","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/rheumatology\/kei140","article-title":"Mechanism of the anti-inflammatory effect of colchicine in rheumatic diseases: a possible new outlook through microarray analysis","volume":"45","author":"Ben-Chetrit","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.mehy.2016.04.039_b0465","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.amjcard.2006.10.039","article-title":"Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease","volume":"99","author":"Nidorf","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.mehy.2016.04.039_b0470","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.jacc.2012.07.031","article-title":"Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: a randomized controlled study","volume":"60","author":"Deftereos","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mehy.2016.04.039_b0475","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7326\/0003-4819-55-2-179","article-title":"Efficacy of colchicine prophylaxis in gout. Prevention of recurrent gouty arthritis over a mean period of five years in 208 gouty subjects","volume":"55","author":"Yu","year":"1961","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mehy.2016.04.039_b0480","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.jacc.2013.01.055","article-title":"Colchicine treatment for the prevention of bare-metal stent restenosis in diabetic patients","volume":"61","author":"Deftereos","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mehy.2016.04.039_b0485","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s002280050244","article-title":"Chronic colchicine treatment does not impair glucose tolerance in familial Mediterranean fever patients","volume":"52","author":"Burstein","year":"1997","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.mehy.2016.04.039_b0490","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.clinthera.2015.03.010","article-title":"Association between colchicine and risk of diabetes among the veterans affairs population with gout","volume":"37","author":"Wang","year":"2015","journal-title":"Clin Ther"},{"key":"10.1016\/j.mehy.2016.04.039_b0495","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mehy.2016.04.039_b0500","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/art.1780340806","article-title":"Long-term colchicine treatment in children with familial Mediterranean fever","volume":"34","author":"Zemer","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.mehy.2016.04.039_b0505","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/bmj.2.6090.808","article-title":"Long-term colchicine prophylaxis in familial Mediterranean fever","volume":"2","author":"Levy","year":"1977","journal-title":"Br Med J"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987716300536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987716300536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T04:36:13Z","timestamp":1567830973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987716300536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":101,"alternative-id":["S0306987716300536"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2016.04.039","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Colchicine to decrease NLRP3-activated inflammation and improve obesity-related metabolic dysregulation","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2016.04.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}